• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服消旋氯喹后氯喹和去乙基氯喹的对映体选择性分析。

Enantioselective analysis of chloroquine and desethylchloroquine after oral administration of racemic chloroquine.

作者信息

Ofori-Adjei D, Ericsson O, Lindström B, Hermansson J, Adjepon-Yamoah K, Sjöqvist F

出版信息

Ther Drug Monit. 1986;8(4):457-61. doi: 10.1097/00007691-198612000-00014.

DOI:10.1097/00007691-198612000-00014
PMID:3824433
Abstract

An enantioselective high-performance liquid chromatographic method for chloroquine and desethylchloroquine was developed using a chiral alpha 1-acid glycoprotein column. This method was used to determine concentrations of chloroquine and desethylchloroquine enantiomers in plasma and urine from volunteers given single oral doses of racemic chloroquine. The disposition of the enantiomers was different. The renal clearance of the chloroquine enantiomers was indicative of stereoselective renal secretion of the drug, and evidence for stereoselective metabolism also was found.

摘要

建立了一种使用手性α1-酸性糖蛋白柱的对映体选择性高效液相色谱法来测定氯喹和去乙基氯喹。该方法用于测定给予单剂量消旋氯喹的志愿者血浆和尿液中氯喹和去乙基氯喹对映体的浓度。对映体的处置情况不同。氯喹对映体的肾清除率表明该药物存在立体选择性肾分泌,并且还发现了立体选择性代谢的证据。

相似文献

1
Enantioselective analysis of chloroquine and desethylchloroquine after oral administration of racemic chloroquine.口服消旋氯喹后氯喹和去乙基氯喹的对映体选择性分析。
Ther Drug Monit. 1986;8(4):457-61. doi: 10.1097/00007691-198612000-00014.
2
Protein binding of chloroquine enantiomers and desethylchloroquine.氯喹对映体和去乙基氯喹的蛋白结合
Br J Clin Pharmacol. 1986 Sep;22(3):356-8. doi: 10.1111/j.1365-2125.1986.tb02900.x.
3
Disposition of chloroquine in man after single intravenous and oral doses.单次静脉注射和口服剂量后氯喹在人体内的处置情况。
Br J Clin Pharmacol. 1983 Apr;15(4):471-9. doi: 10.1111/j.1365-2125.1983.tb01532.x.
4
Liquid chromatographic analysis of chloroquine and desethylchloroquine in human plasma, saliva and urine.人血浆、唾液和尿液中氯喹和去乙基氯喹的液相色谱分析。
J Chromatogr. 1986 Aug 2;380(2):425-30. doi: 10.1016/s0378-4347(00)83674-9.
5
Whole-blood single-dose kinetics of chloroquine and desethylchloroquine in Africans.非洲人氯喹和去乙基氯喹的全血单剂量动力学
Ther Drug Monit. 1986;8(2):195-9. doi: 10.1097/00007691-198606000-00012.
6
Field application of a colorimetric method of assaying chloroquine and desethylchloroquine in urine.尿液中氯喹和去乙基氯喹比色测定法的现场应用
Bull World Health Organ. 1988;66(4):485-90.
7
Metabolites of chloroquine: some observations on desethylchloroquine and N-acetyldesethylchloroquine.氯喹的代谢产物:关于去乙基氯喹和N-乙酰去乙基氯喹的一些观察结果。
J Pharm Sci. 1994 Jul;83(7):1040-2. doi: 10.1002/jps.2600830722.
8
Influence of route of administration on the pharmaco-kinetics of chloroquine and desethylchloroquine.给药途径对氯喹和脱乙基氯喹药代动力学的影响。
Bull World Health Organ. 1987;65(1):47-50.
9
Enantioselective determination of hydroxychloroquine and its major metabolites in urine and the observation of a reversal in the (+)/(-)-hydroxychloroquine ratio.尿液中羟氯喹及其主要代谢物的对映体选择性测定以及(+)/(-)-羟氯喹比例逆转的观察
Chirality. 1993;5(2):65-70. doi: 10.1002/chir.530050205.
10
Quantitative determination of chloroquine and desethylchloroquine in biological fluids by high performance thin layer chromatography.
Acta Trop. 1986 Jun;43(2):125-30.

引用本文的文献

1
Biomimetic properties and estimated in vivo distribution of chloroquine and hydroxy-chloroquine enantiomers.氯喹和羟基氯喹对映体的仿生特性及体内分布估计
ADMET DMPK. 2020 Jan 25;9(2):151-165. doi: 10.5599/admet.929. eCollection 2021.
2
4-Aminoquinoline compounds from the Spanish flu to COVID-19.从西班牙流感到 COVID-19 的 4-氨基喹啉类化合物。
Biomed Pharmacother. 2021 Mar;135:111138. doi: 10.1016/j.biopha.2020.111138. Epub 2020 Dec 15.
3
Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model.
基于生理药代动力学模型的磷酸氯喹治疗新型冠状病毒肺炎的剂量选择
Acta Pharm Sin B. 2020 Jul;10(7):1216-1227. doi: 10.1016/j.apsb.2020.04.007. Epub 2020 Apr 20.
4
Quantum Chemical Lipophilicities of Antimalarial Drugs in Relation to Terminal Half-Life.抗疟药物的量子化学亲脂性与终末半衰期的关系
ACS Omega. 2020 Mar 23;5(12):6500-6515. doi: 10.1021/acsomega.9b04140. eCollection 2020 Mar 31.
5
Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.手性抗疟药物的药效学和药代动力学中的立体选择性。
Clin Pharmacokinet. 2003;42(15):1359-82. doi: 10.2165/00003088-200342150-00004.
6
Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.奎宁、氯喹和阿莫地喹的药代动力学。临床意义。
Clin Pharmacokinet. 1996 Apr;30(4):263-99. doi: 10.2165/00003088-199630040-00002.
7
Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.氯喹的临床药代动力学与代谢。聚焦于近期进展。
Clin Pharmacokinet. 1996 Oct;31(4):257-74. doi: 10.2165/00003088-199631040-00003.
8
Interpretation of chloroquine pharmacokinetic data.氯喹药代动力学数据的解读。
Eur J Clin Pharmacol. 1993;44(4):407-10. doi: 10.1007/BF00316484.
9
Stereoselective pharmacokinetic properties of chloroquine and de-ethyl-chloroquine in humans.氯喹和去乙基氯喹在人体内的立体选择性药代动力学特性。
Clin Pharmacokinet. 1993 Mar;24(3):259-69. doi: 10.2165/00003088-199324030-00007.
10
Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate.多剂量消旋羟氯喹给药后类风湿关节炎患者体内羟氯喹对映体的处置情况。
Br J Clin Pharmacol. 1993 Jul;36(1):78-81. doi: 10.1111/j.1365-2125.1993.tb05897.x.